Arizona 2024 Regular Session

Arizona House Bill HB2174

Introduced
1/10/24  
Report Pass
1/16/24  
Introduced
1/10/24  
Report Pass
1/22/24  
Report Pass
1/16/24  
Engrossed
2/5/24  
Report Pass
1/22/24  
Report Pass
3/6/24  
Engrossed
2/5/24  
Report Pass
3/11/24  
Report Pass
3/6/24  
Enrolled
3/26/24  
Report Pass
3/11/24  
Enrolled
3/26/24  
Passed
3/29/24  
Passed
3/29/24  
Chaptered
3/29/24  

Caption

School personnel; emergency glucagon administration

Impact

The legislation aims to facilitate better management of diabetes in schools by providing a legal framework that outlines the responsibilities of school personnel and the necessary training for administering glucagon. This is particularly significant as it addresses a gap in the current policies concerning diabetic emergencies, thereby promoting the welfare of students with this condition. By formalizing the procedure for glucagon administration, the bill seeks to reduce the instances of severe medical emergencies related to diabetes among students.

Summary

House Bill 2174 addresses comprehensive management practices regarding diabetes for students in Arizona schools. The bill amends various sections of the Arizona Revised Statutes, aiming to establish clear policies and procedures for the administration of glucagon, an emergency treatment for diabetes-related emergencies. Schools will be empowered to create plans that allow trained personnel to administer glucagon, thereby enhancing the safety and health of students suffering from diabetes during school hours or at school-sponsored events.

Sentiment

Overall, the sentiment surrounding HB 2174 appears to be supportive, especially among advocacy groups concerned with childhood diabetes management and healthcare. Stakeholders, including parents of diabetic children, healthcare professionals, and school administrators, have expressed approval of the bill, viewing it as a critical step toward safeguarding student health. The cooperation of educational institutions in implementing these measures demonstrates a proactive approach to health management.

Contention

Some concerns have been raised about the potential liability of school personnel and the adequacy of training provided to them. Opponents of the bill argue that there needs to be a strong emphasis on ensuring that staff members are adequately trained and that schools should not be held liable for unforeseen complications arising from glucagon administration. Despite these concerns, proponents argue that the bill’s civil immunity provision for school personnel who follow the outlined procedures will mitigate fears of legal repercussions, fostering a more secure environment for students with diabetes.

Companion Bills

No companion bills found.

Previously Filed As

AZ SB1535

School personnel; emergency glucagon administration.

AZ SB1649

School personnel; emergency glucagon administration

AZ HB05460

An Act Concerning The Administration Of Glucagon In Schools.

AZ AB450

Ready-to-use glucagon rescue therapies in schools.

AZ SB447

Ready-to-use glucagon rescue therapies in schools.

AZ HB1039

Public elementary and secondary schools; possession and administration of undesignated glucagon.

AZ SB92

Glucagon for Schools Act

AZ SB195

Glucagon for Schools Act

AZ SB293

Creating the Glucagon for Schools Act

AZ B25-0226

Access to Emergency Albuterol and Glucagon Amendment Act of 2023 (now known as "Access to Emergency Medications Amendment Act of 2023")

Similar Bills

AZ SB1649

School personnel; emergency glucagon administration

AZ SB1535

School personnel; emergency glucagon administration.

AZ SB1440

Epinephrine delivery systems

AZ SB1553

Abortion; repeals

AZ HB2564

Hospitals; physicians; dispensing opioids

AZ SB1396

Pharmacy board; duties; regulation

AZ HB2344

Pharmacy board; duties; regulation

AZ HB2468

Unprofessional conduct; health professionals